View more in

Zacks: Analysts Anticipate Avenue Therapeutics, Inc. (NASDAQ:ATXI) Will Post Earnings of -$0.06 Per Share
 6 days ago

Wall Street brokerages predict that Avenue Therapeutics, Inc. (NASDAQ:ATXI) will post ($0.06) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Avenue Therapeutics’ earnings, with the lowest EPS estimate coming in at ($0.07) and the highest estimate coming in at ($0.05). Avenue Therapeutics reported earnings of ($0.08) per share in the same quarter last year, which would indicate a positive year over year growth rate of 25%. The company is expected to announce its next earnings results on Monday, June 14th.